The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium
Abstract
The endothelium lines the luminal surface of every blood vessel, allowing it contact with circulating blood elements, as well as the underlying vascular smooth muscle layer. In healthy vessels, the endothelium expresses constitutive forms of nitric oxide synthase (NOSIII) and cyclo‐oxygenase (COX‐1), which produce the vasoactive hormones NO and prostacyclin, respectively. Both NO and prostacyclin relax blood vessels and inhibit platelet activation. The actions of prostacyclin are mediated by cell surface prostacyclin (IP) receptors and/or intracellular peroxisome proliferator‐activated receptors (PPAR)β. The actions of NO are mediated predominately by activation of intracellular guanylyl cyclase, leading to the formation of cGMP. In platelets, the actions of NO and prostacyclin are synergistic, but in vessels their actions are additive. In diseased vessels, inducible forms of NOS (NOSII) and cyclo‐oxygeanse (COX‐2) are expressed in vascular smooth muscle, resulting in the release of large amounts of NO, prostacyclin and prostaglandin E 2. The relative contribution of NOSII and COX‐2 to vascular inflammation is still debated, but is likely to result in both protective and damaging responses. The relative contribution of constitutive forms of NOS and COX, as well as interactions between IP, PPARβ and guanylyl cyclase pathways in vessels and platelets, is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,729
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Vascular endothelial cells synthesize nitric oxide from L-arginine
Palmer, R. M. J., Ashton, D. S., & Moncada, S. (1988) · Nature · doi:10.1038/333664a0 · Cited by 4,769
Moncada, S., Gryglewski, R., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,595
Forman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Oliver, W. R., Shenk, J. L., Snaith, M. R., Russell, C. S., Plunket, K. D., Bodkin, N. L., Lewis, M. C., Winegar, D. A., Sznaidman, M. L., Lambert, M. H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091021198 · Cited by 1,046
Dynamic activation of endothelial nitric oxide synthase by Hsp90
García-Cardeña, G., Fan, R., Shah, V., Sorrentino, R., Cirino, G., Papapetropoulos, A., & Sessa, W. C. (1998) · Nature · doi:10.1038/33934 · Cited by 1,029
Prostanoid Receptors: Subtypes and Signaling
Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.661 · Cited by 1,011
Pollock, J. S., Förstermann, U., Mitchell, J. A., Warner, T. D., Schmidt, H. H., Nakane, M., & Murad, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10480 · Cited by 980
Self-citationDifferential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids
Yu, K., Bayona, W., Kallen, C. B., Harding, H. P., Ravera, C. P., McMahon, G., Brown, M., & Lazar, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23975 · Cited by 711
Acetylcholine releases endothelium‐derived hyperpolarizing factor and EDRF from rat blood vessels
Chen, G., Suzuki, H., & Weston, A. H. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11752.x · Cited by 688
Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta
Lim, H., Gupta, R. A., Ma, W.-G., Paria, B. C., Moller, D. E., Morrow, J. D., DuBois, R. N., Trzaskos, J. M., & Dey, S. K. (1999) · Genes & Development · doi:10.1101/gad.13.12.1561 · Cited by 587
Sessa, W. C. (2004) · Journal of Cell Science · doi:10.1242/jcs.01165 · Cited by 561
Abramovitz, M., Adam, M., Boie, Y., Carrière, M.-C., Denis, D., Godbout, C., Lamontagne, S., Rochette, C., Sawyer, N., Tremblay, N. M., et al. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00164-x · Cited by 557
Needleman, P., Moncada, S., Bunting, S., Vane, J. R., Hamberg, M., & Samuelsson, B. (1976) · Nature · doi:10.1038/261558a0 · Cited by 526
Endothelium-Derived Hyperpolarizing Factor: Where Are We Now?
Félétou, M., & Vanhoutte, P. M. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000217611.81085.c5 · Cited by 488
Berger, J., Leibowitz, M. D., Doebber, T. W., Elbrecht, A., Zhang, B., Zhou, G., Biswas, C., Cullinan, C. A., Hayes, N. S., Li, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6718 · Cited by 410
Nitric Oxide and the Vascular Endothelium
Moncada, S., & Higgs, E. A. (2006) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-32967-6_7 · Cited by 408
Michalik, L., Desvergne, B., Tan, N. S., Basu-Modak, S., Escher, P., Rieusset, J., Peters, J. M., Kaya, G., Gonzalez, F. J., Zakany, J., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200011148 · Cited by 406
Tare, M., Parkington, H. C., Coleman, H. A., Neild, T. O., & Dusting, G. J. (1990) · Nature · doi:10.1038/346069a0 · Cited by 396
Cloning and expression of a cDNA for the human prostanoid FP receptor.
Abramovitz, M., Boie, Y., Nguyen, T., Rushmore, T. H., Bayne, M. A., Metters, K. M., Slipetz, D. M., & Grygorczyk, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41991-0 · Cited by 380
Peroxisome proliferator-activated receptors and inflammation
Moraes, L. A., Piqueras, L., & Bishop-Bailey, D. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.08.007 · Cited by 376
Schwarz, U. R., Walter, U., & Eigenthaler, M. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00760-2 · Cited by 329
Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
Mitchell, J. A., & Warner, T. D. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702897 · Cited by 321
Self-citationLückhoff, A., Pohl, U., Mülsch, A., & Busse, R. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb16564.x · Cited by 312
Sznaidman, M. L., Haffner, C. D., Maloney, P. R., Fivush, A., Chao, E., Goreham, D., Sierra, M. L., LeGrumelec, C., Xu, H. E., Montana, V. G., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00207-5 · Cited by 312
Mitchell, J. A., & Warner, T. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1929 · Cited by 279
Self-citationde Nucci, G., Gryglewski, R. J., Warner, T. D., & Vane, J. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2334 · Cited by 267
NO, nitrotyrosine, and cyclic GMP in signal transduction.
Hanafy, K. A., Krumenacker, J. S., & Murad, F. (2001) · PubMed · Cited by 236
Endothelin-1: The Yin and Yang on Vascular Function
Marasciulo, F., Montagnani, M., & Potenza, M. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777441968 · Cited by 195
Cloning and expression of a cDNA for the human prostanoid IP receptor.
Boie, Y., Rushmore, T. H., Darmon-Goodwin, A., Grygorczyk, R., Slipetz, D. M., Metters, K. M., & Abramovitz, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32697-2 · Cited by 195
Akbiyik, F., Ray, D. M., Gettings, K. F., Blumberg, N., Francis, C. W., & Phipps, R. P. (2004) · Blood · doi:10.1182/blood-2004-03-0926 · Cited by 191
Mitchell, J. A., Paul‐Clark, M. J., Clarke, G. W., McMaster, S. K., & Cartwright, N. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0067 · Cited by 150
Self-citationNitric oxide synthases domain structure and alignment in enzyme function and control
Ghosh, D. K., & Salerno, J. C. (2003) · Frontiers in bioscience · doi:10.2741/959 · Cited by 147
Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARβ
Ali, F. Y., Davidson, S. J., Moraes, L. A., Traves, S. L., Paul‐Clark, M. J., Bishop‐Bailey, D., Warner, T. D., & Mitchell, J. A. (2005) · The FASEB Journal · doi:10.1096/fj.05-4395fje · Cited by 132
Self-citationNakagawa, O., Tanaka, I., Usui, T., Harada, M., Sasaki, Y., Itoh, H., Yoshimasa, T., Namba, T., Narumiya, S., & Nakao, K. (1994) · Circulation · doi:10.1161/01.cir.90.4.1643 · Cited by 112
Cloning and expression of a cDNA for the human prostacyclin receptor
Katsuyama, M., Sugimoto, Y., Namba, T., Irie, A., Negishi, M., Narumiya, S., & Ichikawa, A. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00355-6 · Cited by 104
PPARδ Functions as a Prostacyclin Receptor in Blastocyst Implantation
Lim, H. J., & Dey, S. K. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00243-5 · Cited by 101
Ali, F. Y., Egan, K. M., FitzGerald, G. A., Desvergne, B., Wahli, W., Bishop‐Bailey, D., Warner, T. D., & Mitchell, J. A. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0289oc · Cited by 98
Self-citationNongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets
Moraes, L. A., Swales, K. E., Wray, J. A., Damazo, A. S., Gibbins, J. M., Warner, T. D., & Bishop‐Bailey, D. (2007) · Blood · doi:10.1182/blood-2006-05-022566 · Cited by 84
Mitchell, J. A., Lucas-Domínguez, R., Vojnovic, I., Hasan, K., Pepper, J., & Warner, T. D. (2006) · The FASEB Journal · doi:10.1096/fj.06-6615com · Cited by 82
Self-citationApoptotic cells induce arginase II in macrophages, thereby attenuating NO production
Johann, A. M., Barra, V., Kühn, A., Weigert, A., von Knethen, A., & Brüne, B. (2007) · The FASEB Journal · doi:10.1096/fj.06-7815com · Cited by 68
Human prostacyclin receptor structure and function from naturally-occurring and synthetic mutations
Stitham, J., Arehart, E. J., Gleim, S., Douville, K. L., & Hwa, J. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.05.010 · Cited by 43
Different patterns of release of endothelium‐derived relaxing factor and prostacyclin
Mitchell, J. A., Nucci, G. D., Warner, T. D., & Vane, J. R. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14280.x · Cited by 37
Self-citationNovel Peroxisome Proliferator Activated Receptor–α Agonists
Fruchart, J. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.08.012 · Cited by 36
Mediators and the Anti-Thrombotic Properties of the Vascular Endothelium
Botting, R., & Vane, J. R. (1989) · Annals of Medicine · doi:10.3109/07853898909149179 · Cited by 24
Pollock, J. S., Werner, E. R., Mitchell, J. A., & Förstermann, U. (1993) · Endothelium · doi:10.3109/10623329309102690 · Cited by 15
Self-citation
Cited by
Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation
Marchio, P., Guerra-Ojeda, S., Vila, J. M., Aldasoro, M., Victor, V. M., & Mauricio, M. D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8563845 · Cited by 621
Cocoa and Chocolate in Human Health and Disease
Katz, D. L., Doughty, K., & Ali, A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3697 · Cited by 441
Is Flow-Mediated Dilation Nitric Oxide Mediated?: A Meta-Analysis
Green, D. J., Dawson, E. A., Groenewoud, H. M. M., Jones, H., & Thijssen, D. H. J. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02044 · Cited by 360
Pandey, A. K., Singhi, E. K., Arroyo, J. P., Ikizler, T. A., Gould, E. R., Brown, J., Beckman, J. A., Harrison, D. G., & Moslehi, J. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10271 · Cited by 338
The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art
Esse, R., Barroso, M., Tavares de Almeida, I., & Castro, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040867 · Cited by 336
Metadata
- Authors
- Mitchell, J. A., Ali, F., Bailey, L., Moreno, L., & Harrington, L. S.
- Venue
- Experimental Physiology
- Publisher
- Wiley
- Published
- 2007-11-26
- Volume
- 93
- Issue
- 1
- Pages
- 141-147
- ISSN
- 0958-0670 (ISSN-L)
- 1469-445X
- OpenAlex
- W1590845064
- Cited by
- 291
- References
- 47
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.